NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/30/2024
Back to search
Official data from USPTO
BIOSPRING THE NUCLEIC ACID COMPANY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
04/30/2024
Classification
Registered
Trademark type
Combined
Nice classes
1, 5, 42
Filing date
10/29/2021
Registration date
04/30/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/30/2024
Last transaction
04/30/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
04/30/2017
First use in commerce
04/30/2017
Drawing code
3
Owner type
16
Owner location
Frankfurt, DD
Examiner
PURATH,ANICKA S
Law office
L10
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording "BIOSPRING" centered above the wording "THE NUCLEIC ACID COMPANY". A stylized DNA helix design with an incomplete circle surrounding the center of the helix is featured inside a circle that appears to the left of the wording.
Holders and representatives
Holders
B. M. (pessoa física)
BioSpring Gesellschaft für Biotechnologie GmbH
Representatives
Julie A. Katz KATZ GROUP LLC
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Nucleic acid for laboratory or research use; Nucleic acid for use in the manufacture of pharmaceuticals; Oligonucleotides for laboratory or research use; Oligonucleotides for use in the manufacture of pharmaceuticals
Class 5
Nucleic acid for medical diagnostic purposes; Oligonucleotides for medical diagnostic purposes; Oligonucleotides for pharmaceutical purposes
Class 42
Scientific research services, namely, nucleic acid analysis; Scientific research services, namely, oligonucleotide analysis
Publications
History of USPTO decisions and trademark events.
36 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
04/30/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
03/26/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/25/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/08/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/08/2024
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
03/07/2024
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
02/12/2024
GNFR
FINAL REFUSAL E-MAILED
02/12/2024
CNFR
SU - FINAL REFUSAL - WRITTEN
02/12/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/16/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/16/2024
ALIE
ASSIGNED TO LIE
01/16/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/23/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/21/2023
GNRT
NON-FINAL ACTION E-MAILED
08/21/2023
CNRT
SU - NON-FINAL ACTION - WRITTEN
08/21/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
07/25/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
07/25/2023
IUAF
USE AMENDMENT FILED
07/03/2023
EISU
TEAS STATEMENT OF USE RECEIVED
07/03/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/03/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/08/2022
PUBO
PUBLISHED FOR OPPOSITION
11/08/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/19/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/03/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/21/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/21/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/21/2022
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
08/16/2022
GPRA
PRIORITY ACTION E-MAILED
08/16/2022
CPRA
PRIORITY ACTION WRITTEN
08/16/2022
DOCK
ASSIGNED TO EXAMINER
08/09/2022
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
11/11/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/10/2021
NWAP
NEW APPLICATION ENTERED
11/02/2021
Continuous trademark protection
Get notified about every new filing that threatens BIOSPRING THE NUCLEIC ACID COMPANY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.